Medtronic Total Assets Growth & History (MDT)
Medtronic's total assets was $93.03B for fiscal 2026.
View full Medtronic company overviewMedtronic annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $93.03B | $1.35B | +1.47% |
| 2025 | 2025-04-25 | $91.68B | $1.70B | +1.89% |
| 2024 | 2024-04-26 | $89.98B | −$967.0M | −1.06% |
| 2023 | 2023-04-28 | $90.95B | −$33.0M | −0.04% |
| 2022 | 2022-04-29 | $90.98B | −$2.10B | −2.26% |
| 2021 | 2021-04-30 | $93.08B | $2.39B | +2.64% |
| 2020 | 2020-04-24 | $90.69B | $995.0M | +1.11% |
| 2019 | 2019-04-26 | $89.69B | −$1.70B | −1.86% |
| 2018 | 2018-04-27 | $91.39B | −$8.46B | −8.48% |
| 2017 | 2017-04-28 | $99.86B | $213.0M | +0.21% |
| 2016 | 2016-04-29 | $99.64B | −$7.04B | −6.60% |
| 2015 | 2015-04-24 | $106.69B | $68.74B | +181.17% |
| 2014 | 2014-04-25 | $37.94B | — | — |
Medtronic quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $93.31B | $2.33B | +2.57% |
| Q4 2026 | 2026-04-24 | $93.03B | $1.35B | +1.47% |
| Q3 2026 | 2026-01-31 | $91.48B | $1.51B | +1.68% |
| Q3 2026 | 2026-01-23 | $91.48B | $1.51B | +1.68% |
| Q2 2026 | 2025-10-24 | $91.35B | $1.30B | +1.45% |
| Q1 2026 | 2025-07-25 | $90.97B | $1.22B | +1.36% |
| Q4 2025 | 2025-04-25 | $91.68B | $1.70B | +1.89% |
| Q3 2025 | 2025-01-24 | $89.97B | −$863.0M | −0.95% |
| Q2 2025 | 2024-10-25 | $90.04B | −$45.0M | −0.05% |
| Q1 2025 | 2024-07-26 | $89.75B | −$1.03B | −1.13% |
| Q4 2024 | 2024-04-26 | $89.98B | −$967.0M | −1.06% |
| Q3 2024 | 2024-01-26 | $90.84B | −$3.30B | −3.50% |
| Q2 2024 | 2023-10-27 | $90.09B | −$3.15B | −3.38% |
| Q1 2024 | 2023-07-28 | $90.78B | $862.0M | +0.96% |
| Q4 2023 | 2023-04-28 | $90.95B | −$33.0M | −0.04% |
| Q3 2023 | 2023-01-27 | $94.13B | $2.33B | +2.54% |
| Q2 2023 | 2022-10-28 | $93.24B | $1.49B | +1.62% |
| Q1 2023 | 2022-07-29 | $89.91B | −$1.89B | −2.06% |
| Q4 2022 | 2022-04-29 | $90.98B | −$2.10B | −2.26% |
| Q3 2022 | 2022-01-28 | $91.80B | −$5.47B | −5.62% |
| Q2 2022 | 2021-10-29 | $91.76B | −$4.13B | −4.31% |
| Q1 2022 | 2021-07-30 | $91.80B | −$2.10B | −2.24% |
| Q4 2021 | 2021-04-30 | $93.08B | $2.39B | +2.64% |
| Q3 2021 | 2021-01-29 | $97.27B | $4.45B | +4.79% |
| Q2 2021 | 2020-10-30 | $95.89B | $4.83B | +5.31% |
| Q1 2021 | 2020-07-31 | $93.91B | $2.64B | +2.89% |
| Q4 2020 | 2020-04-24 | $90.69B | $995.0M | +1.11% |
| Q3 2020 | 2020-01-24 | $92.82B | $4.09B | +4.61% |
| Q2 2020 | 2019-10-25 | $91.05B | $2.90B | +3.29% |
| Q1 2020 | 2019-07-26 | $91.27B | $1.55B | +1.72% |
| Q4 2019 | 2019-04-26 | $89.69B | −$1.70B | −1.86% |
| Q3 2019 | 2019-01-25 | $88.73B | −$7.07B | −7.38% |
| Q2 2019 | 2018-10-26 | $88.15B | −$6.31B | −6.68% |
| Q1 2019 | 2018-07-27 | $89.72B | −$10.53B | −10.50% |
| Q4 2018 | 2018-04-27 | $91.39B | −$8.46B | −8.48% |
| Q3 2018 | 2018-01-26 | $95.80B | −$1.78B | −1.82% |
| Q2 2018 | 2017-10-27 | $94.46B | −$3.95B | −4.01% |
| Q1 2018 | 2017-07-28 | $100.25B | $1.65B | +1.67% |
| Q4 2017 | 2017-04-28 | $99.86B | $213.0M | +0.21% |
| Q3 2017 | 2017-01-27 | $97.58B | −$5.13B | −4.99% |
| Q2 2017 | 2016-10-28 | $98.41B | −$6.54B | −6.23% |
| Q1 2017 | 2016-07-29 | $98.60B | −$6.03B | −5.76% |
| Q4 2016 | 2016-04-29 | $99.64B | −$7.04B | −6.60% |
| Q3 2016 | 2016-01-29 | $102.71B | — | — |
| Q2 2016 | 2015-10-30 | $104.94B | — | — |
| Q1 2016 | 2015-07-31 | $104.63B | — | — |
| Q4 2015 | 2015-04-24 | $106.69B | $68.74B | +181.17% |
| Q4 2014 | 2014-04-25 | $37.94B | — | — |
Medtronic total assets trends
Over the last five fiscal years, Medtronic's total assets decreased from $93.08B to $93.03B, a change of −$55.0M. The latest reported quarter, Q1 2027, shows $93.31B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...